Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,233 | -386 | -38 | -4 | -7 |
| Depreciation Amortization | 11 | 0 | 0 | N/A | N/A |
| Accounts receivable | N/A | 212 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 87 | N/A | N/A | N/A | N/A |
| Other Working Capital | 306 | 202 | -2 | N/A | N/A |
| Other Operating Activity | 8,005 | -212 | 0 | 0 | 0 |
| Operating Cash Flow | $-1,824 | $-183 | $-40 | $-4 | $-7 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -693 | -3 | -3 | N/A | N/A |
| Other Investing Activity | -1,053 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,746 | $-3 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150 | 150 | N/A | N/A | N/A |
| Common Stock Issued | 56,741 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 61 | 62 | 43 | 4 | 7 |
| Financing Cash Flow | $56,952 | $212 | $43 | $4 | $7 |
| End Cash Position | 53,382 | 26 | N/A | N/A | N/A |
| Net Cash Flow | $53,382 | $26 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,824 | -183 | -40 | -4 | -7 |
| Capital Expenditure | -693 | -3 | -3 | N/A | N/A |
| Free Cash Flow | -2,517 | -187 | -43 | -4 | -7 |